New Drug Update 2017

Published by Texas Pharmacy Association


Description: Every year the U.S. Food and Drug Administration approves a number of new drugs for use. In some cases, these new agents represent significant advancements over older, more established treatments. In other instances, however, marketing practices by pharmaceutical companies result in widespread use of some new drugs over less costly, commonly used agents with similar risks and benefits to patients. This seminar will review some recently approved drugs with an emphasis on their pharmacology, clinical efficacy, adverse effects, drug interactions, and monitoring requirements. Attendees will learn practical information about the new drugs presented, which in turn, they can use in their interactions with prescribers and in the care and counseling of their patients.

At the completion of this activity, pharmacists will be able to:
1. Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions relate to both therapeutic and adverse effects.
2. Discuss clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.
3. Discuss the therapeutic role of the new drugs presented as compared to agents already marketed.

At the completion of this activity, technicians will be able to:
1. List the new drugs presented.
2. Describe clinically significant adverse effects and drug interactions, and the appropriate dosing and monitoring of the new drugs presented.

”ACPE Texas Pharmacy Association (154) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Continuing education will be provided to participants who completed all course requirements.


ACPE 0154-0000-17-012-H01-P
ACPE 0154-0000-17-012-H01-T

This lesson is a knowledge-based CE activity and is targeted to pharmacists and technicians. This program has been approved for 1.5 contact hours of continuing education credit (0.15 CEUs).

Bryson Duhon, Pharm.D.
Laurajo Ryan, Pharm.D., MSc, BCPS, CDE
Clinical Assistant Professor at the University of Texas at Austin College of Pharmacy and the University of Texas Health Science Center San Antonio

Originally Published

July 7, 2017

Program Titles and Supporting Materials

This program contains the following components:

  • New Drug Update 2017 - Video
  • New Drug Update 2017 - Paper

How To Attend

Join the self-paced program from your office, home, or hotel room using a computer and high speed internet connection. You may start and stop the program at your convenience, continue where you left off, and review supporting materials as often as you like.

Technical Requirements

You may access this course on a computer or mobile device with high speed internet (iPhones require iOS 10 or higher). Recommended browsers are Google Chrome or Mozilla Firefox.


If applicable, you may obtain credit in multiple jurisdictions simultaneously for this program (see pending/approved list below). If electing credit for this program, registrants in jurisdictions not listed below will receive a Certificate of Completion that may or may not meet credit requirements in other jurisdictions. Where applicable, credit will be only awarded to a paid registrant completing all the requirements of the program as determined by the selected accreditation authority.

Click on jurisdiction for specific details

Refund Policy

SeminarWeb and Texas Pharmacy Association programs are non-refundable.

Privacy Statement

We respect and are committed to protecting your privacy. (Read Statement)

Tell a Colleague!


For immediate assistance please consult our FAQ page.

If you're unable to find the answer you need, please call 800-701-5161 (M-F, 8am-6pm CT) or e-mail customer service.

Powered by

Powered by